Compile Data Set for Download or QSAR
Report error Found 95 of ic50 data for complexid = 188
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707434(US20240409538, Example 38)
Affinity DataIC50: 5.44nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707433(US20240409538, Example 37)
Affinity DataIC50: 9.53nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707417(US20240409538, Example 18)
Affinity DataIC50: 11.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707423(US20240409538, Example 25)
Affinity DataIC50: 11.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707422(US20240409538, Example 24)
Affinity DataIC50: 11.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707416(US20240409538, Example 16)
Affinity DataIC50: 15.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707419(US20240409538, Example 21)
Affinity DataIC50: 16.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM50069762(CHEMBL3182437 | ML323 | US9802904, 87)
Affinity DataIC50: 17nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707415(US20240409538, Example 15)
Affinity DataIC50: 17.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707435(US20240409538, Example 39)
Affinity DataIC50: 18.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707436(US20240409538, Example 40)
Affinity DataIC50: 19.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707426(US20240409538, Example 28)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707414(US20240409538, Example 14)
Affinity DataIC50: 30.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352028(US9802904, 89)
Affinity DataIC50: 34nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707437(US20240409538, Example 41)
Affinity DataIC50: 34.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707427(US20240409538, Example 29)
Affinity DataIC50: 34.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707439(US20240409538, Example 43)
Affinity DataIC50: 38.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707412(US20240409538, Example 5)
Affinity DataIC50: 39.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707424(US20240409538, Example 26)
Affinity DataIC50: 39.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707428(US20240409538, Example 30)
Affinity DataIC50: 41.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM350387(US9802904, 60)
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352011(US9802904, 72)
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352013(US9802904, 74)
Affinity DataIC50: 48nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707429(US20240409538, Example 31)
Affinity DataIC50: 57.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352018(US9802904, 79)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM351737(US9802904, 61)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352025(US9802904, 86)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707411(US20240409538, Example 4)
Affinity DataIC50: 66.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM350386(US9802904, 59)
Affinity DataIC50: 68nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM50069762(CHEMBL3182437 | ML323 | US9802904, 87)
Affinity DataIC50: 76nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707425(US20240409538, Example 27)
Affinity DataIC50: 77.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707440(US20240409538, Example 44)
Affinity DataIC50: 78.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM351922(US9802904, 64)
Affinity DataIC50: 86nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707431(US20240409538, Example 33)
Affinity DataIC50: 94.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707441(US20240409538, Example 45)
Affinity DataIC50: 99.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707430(US20240409538, Example 32)
Affinity DataIC50: 111nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM350385(US9802904, 59)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM350377(US9802904, 51)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352015(US9802904, 76)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707418(US20240409538, Example 19)
Affinity DataIC50: 138nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM351934(US9802904, 66)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM351941(US9802904, 67)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM350383(US9802904, 57)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707420(US20240409538, Example 22)
Affinity DataIC50: 147nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM351827(US9802904, 63)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352027(US9802904, 88)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM350384(US9802904, 58)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM707421(US20240409538, Example 23)
Affinity DataIC50: 175nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM352029(US9802904, 90)
Affinity DataIC50: 190nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Impact Therapeutics (Shanghai)

US Patent
LigandPNGBDBM351968(US9802904, 69)
Affinity DataIC50: 220nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 95 total ) | Next | Last >>
Jump to: